MENU
APR 22, 2020 9:00 AM PDT

From Data to Biological Insight using QIAGEN OmicSoft and IPA: Single Cell Sequencing of Normal Human Liver

Sponsored by: QIAGEN
Speaker

Abstract

Single-cell RNA sequencing has emerged as an important technology that can reveal gene expression differences between different cell types. This webinar will demonstrate how bioinformatics solutions from QIAGEN Digital Insights were used to analyze and interpret whole transcriptome data from a human single-cell sequencing experiment. Using a public dataset from normal liver from deceased donors that has been carefully curated and processed for the QIAGEN OmicSoft Land database, we will describe the gene expression differences between cell types, and illuminate the underlying biology using QIAGEN Ingenuity Pathway Analysis (IPA).

Learning Objectives:

1. Identify single-cell RNA-sequencing projects of interest within QIAGEN OmicSoft

2. Download a Single Cell Land Project of choice into QIAGEN OmicSoft Suite (Array Studio) and analyze and visualize gene expression differences in different cell types, or within a unique cell type

3. Compare gene signatures enriched in clusters of cells versus tens of thousands of gene expression signatures in QIAGEN IPA to pinpoint significant genes associated with hepatic or immune function

4. Identify significant cell-specific canonical pathways or function-specific regulators

5. Generate hypotheses about novel regulatory networks that suggest drivers of the expression changes observed in the different cell types

6. Visualize important information regarding a gene of interest in other contexts (disease, expression)

7. Gain additional insights about single cell biology by comparing this human liver cellular landscape dataset in QIAGEN IPA to more than 60,000 additional public datasets which have been curated and processed in QIAGEN OmicSoft Suite


Show Resources
You May Also Like
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 16, 2022 10:00 AM PDT
JUN 16, 2022 10:00 AM PDT
Date: June 16, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
Loading Comments...
Show Resources